HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Portfolio Pulse from Lisa Levin
Wall Street analysts have updated their price targets and ratings for several stocks. Citigroup upgraded HP Inc. (HPQ) to Buy and raised its price target, resulting in a 2.2% rise in HP's shares. UBS upgraded Noah Holdings (NOAH) to Buy, with shares up 1.6% in pre-market trading. Piper Sandler upgraded Health Catalyst (HCAT) to Overweight despite a price target cut. AXIS Capital (AXS) was upgraded by Keefe, Bruyette & Woods to Outperform with a higher price target. HC Wainwright maintained a Buy rating on Nouveau Monde Graphite (NMG) but lowered its price target. Wells Fargo downgraded Barings BDC (BBDC) and Crescent Capital BDC (CCAP) to Equal-Weight with reduced price targets. B of A Securities downgraded Paramount Group (PGRE) to Underperform with a lower price target. Barclays downgraded Waters Corporation (WAT) to Underweight and reduced its price target. Goldman Sachs maintained a Neutral rating on GoodRx Holdings (GDRX) but cut its price target.
November 13, 2023 | 1:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AXIS Capital was upgraded by Keefe, Bruyette & Woods to Outperform with a price target increase from $59 to $66, and shares rose 0.9%.
The upgrade to Outperform and the higher price target indicate a positive sentiment that could lead to further appreciation in AXS's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Piper Sandler upgraded Health Catalyst to Overweight, despite lowering the price target from $12 to $11, and shares gained 3.1% in pre-market trading.
The upgrade to Overweight by Piper Sandler suggests a bullish outlook, which may outweigh the negative impact of a reduced price target in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Citigroup upgraded HP Inc. to Buy and raised the price target from $31 to $33, which led to a 2.2% rise in HP's shares.
The upgrade by Citigroup to a Buy rating and the increase in price target are strong positive signals that could lead to a short-term rally in HPQ's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
HC Wainwright maintained a Buy rating on Nouveau Monde Graphite but lowered the price target from $9 to $8, with shares up 2.6% in pre-market trading.
Although the price target was reduced, the maintenance of a Buy rating and the pre-market share increase suggest a positive short-term outlook for NMG.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
UBS upgraded Noah Holdings to Buy and increased the price target from $16.3 to $18, with shares up 1.6% in pre-market trading.
The upgrade to Buy and the raised price target by UBS may contribute to a positive short-term price movement for NOAH.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Wells Fargo downgraded Barings BDC to Equal-Weight and cut the price target from $9 to $8.5, with shares falling 1.6% in pre-market trading.
The downgrade to Equal-Weight and the reduced price target by Wells Fargo are likely to have a negative short-term impact on BBDC's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Wells Fargo downgraded Crescent Capital BDC to Equal-Weight and slashed the price target from $16.5 to $16, with shares down 1.4% in pre-market trading.
The downgrade and price target cut by Wells Fargo suggest a bearish sentiment that could negatively affect CCAP's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Goldman Sachs maintained a Neutral rating on GoodRx Holdings and lowered the price target from $7 to $6, with shares declining 1.7% in pre-market trading.
The price target cut by Goldman Sachs, despite maintaining a Neutral rating, could contribute to a negative short-term trend for GDRX's stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
B of A Securities downgraded Paramount Group to Underperform and reduced the price target from $5 to $4, with shares falling 3% in pre-market trading.
The downgrade to Underperform and a significant price target reduction are likely to exert downward pressure on PGRE's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Barclays downgraded Waters Corporation to Underweight and cut the price target from $270 to $230, despite a 1.1% gain in shares.
The downgrade to Underweight and the lowered price target by Barclays could overshadow the recent share gain and lead to a negative short-term impact on WAT's stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85